Psilonautica provides political and scientific consultancy to support the growing industry of psychedelics as medicines. The aim of Psilonautica is to bridge the gap between scientific research and government policy.
“Drawing from our experience in medical psychedelic regulation, drug policy and ethics, we provide political and scientific consultancy, undertake project-specific work that addresses critical research questions, and nurtures the growth of a principled, patient-centred industry.”
Psilonautica
In May 2021 the group released a report, made together with YouGov, that polled a representative sample of those in the UK about their attitudes towards psychedelics.
Key Staff
- Eddie Jacobs – Director of Research
- James Bunn
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates